Solid Biosciences Inc. SLDB
6.25 USD -0.19 (-2.95%)
Regular-session close
6.25 0.00 0.00%
After hours · Nov 20, 4:01 PM ET
6.20 Day range 6.53
4.45 52-week range 11.45
- YTD
- +10.82%
- 1 year
- +40.13%
Held by funds
90 US ETFs and mutual funds hold SLDB · largest positions
- VTI 0.00% of fund $22.76M
- FBIOX 0.32% of fund $18.85M
- IWM 0.02% of fund $14.01M
- XBI 0.12% of fund $13.03M
- CGOAX 0.34% of fund $10.91M
- NJM 0.01% of fund $9.38M
- FSSNX 0.02% of fund $8.28M
- VXF 0.01% of fund $5.29M
- FBTTX 0.21% of fund $4.90M
- IBB 0.04% of fund $4.75M
- DFAS 0.01% of fund $4.37M
- FESM 0.06% of fund $3.83M
- FSCRX 0.16% of fund $3.46M
- NAJ 0.02% of fund $3.42M
- VTWO 0.02% of fund $3.17M
- IWN 0.02% of fund $2.56M
- IWO 0.02% of fund $2.48M
- SCHA 0.01% of fund $2.42M
- FSMAX 0.01% of fund $2.19M
- IWC 0.13% of fund $1.64M
Ownership
Held by insiders 0.68%
Held by institutions 107.26%
Float held by institutions 107.99%
Institutions 215
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RA Capital Management, L.P. | 11.23% | 12,036,126 | 114.82M | Jun 29, 2026 |
| Perceptive Advisors Llc | 11.10% | 11,906,646 | 113.59M | Jun 29, 2026 |
| Bain Capital Life Sciences Investors, LLC | 9.15% | 9,808,819 | 93.58M | Jun 29, 2026 |
| Siren, L.L.C. | 7.17% | 7,690,405 | 73.37M | Jun 29, 2026 |
| Blackrock Inc. | 6.47% | 6,934,248 | 66.15M | Jun 29, 2026 |
| FMR, LLC | 6.41% | 6,875,957 | 65.60M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.94% | 3,148,576 | 30.04M | Jun 29, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 2.43% | 2,606,779 | 24.87M | Jul 30, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.37% | 2,536,385 | 24.20M | Jul 30, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.91% | 2,052,984 | 19.59M | Jun 29, 2026 |
| Columbia Funds Series Trust I-Columbia Small Cap Growth Fund | 1.38% | 1,476,030 | 14.08M | May 30, 2026 |
| Franklin Strategic Series-Franklin Biotechnology Discovery Fund | 1.17% | 1,253,978 | 11.96M | Apr 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ADAGE CAPITAL MANAGEMENT, L.P. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 17, 2025 | 0 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 18, 2025 | 0 |
| BROOKS GABRIEL M.D. | Officer | Sale | Feb 17, 2026 | 89,466 |
| CUMBO ALEXANDER | Chief Executive Officer | Sale | Feb 17, 2026 | 235,405 |
| GANOT ILAN | Director | Sale | Feb 17, 2026 | 0 |
| HANRAHAN JESSIE | Officer | Sale | Feb 17, 2026 | 74,318 |
